MARKET

INMB

INMB

Inmune Bio Inc
NASDAQ
1.050
0.000
0.00%
After Hours: 1.090 +0.04 +3.81% 16:53 11/13 EST
OPEN
1.060
PREV CLOSE
1.050
HIGH
1.087
LOW
1.020
VOLUME
476.50K
TURNOVER
--
52 WEEK HIGH
2.600
52 WEEK LOW
1.010
MARKET CAP
32.51M
P/E (TTM)
-1.6971
1D
5D
1M
3M
1Y
5Y
1D
INmune Bio Price Target Cut to $2.50/Share From $4.00 by Freedom Broker
Dow Jones · 4h ago
INmune Bio Is Maintained at Buy by Freedom Broker
Dow Jones · 4h ago
Freedom Broker Maintains Buy on INmune Bio, Lowers Price Target to $2.5
Benzinga · 4h ago
INmune Bio price target lowered to $2.50 from $4 at Freedom Broker
TipRanks · 10h ago
INmune Bio Advances Ebstrocel Toward 2027 Approval as Financing and Pipeline Strengthen Outlook
TipRanks · 2d ago
QUBT Stock Drops 4% After Earnings Despite 2,374% Q3 Revenue Surge
TipRanks · 3d ago
Weekly Report: what happened at INMB last week (1102-1106)?
Weekly Report · 4d ago
INmune Bio (INMB) Q3 2026 Earnings Call Transcript
The Motley Fool · 11/06 17:17
More
About INMB
INmune Bio Inc. is a clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. The Company has three product platforms. The Dominant-Negative Tumor Necrosis Factor (DN-TNF) product platform utilizes dominant-negative technology to selectively neutralize soluble TNF. DN-TNF product candidates are in clinical trials to determine if they can treat Mild Alzheimer’s disease, Mild Cognitive Impairment and treatment-resistant depression (XPro). The Natural Killer Cell Priming Platform includes INKmune, developed to prime a patient’s NK cells to eliminate minimal residual disease in patients with cancer and is in trials in metastatic castration-resistance prostate cancer. The third program, CORDStrom, is a proprietary pooled, allogeneic, human umbilical cord-derived mesenchymal Stromal/Stem cell (hucMSCs) platform that has completed a trial in recessive dystrophic epidermolysis bullosa.

Webull offers INmune Bio Inc stock information, including NASDAQ: INMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INMB stock methods without spending real money on the virtual paper trading platform.